Proteomics Research of Breast Cancer Markers in Interstitial Fluid and Serum
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
|Official Title:||Proteomics Research of Breast Cancer Markers in Interstitial Fluid and Serum|
Subjects will be asked to allow us to collect an extra 2 tablespoons of blood at the time of pre-operative blood work. For those subjects with cancer who undergo surgery, a follow-up blood sample will be collected prior to chemotherapy, radiation, or hormonal therapy, and every six months afterwards at the time of their standard clinic/office visit for two years, then once a year for year 3-5. This will allow researchers to examine the samples to determine if blood changes over time after surgery, and what type of result may indicate a risk for recurrence.
Any remaining blood samples not used for the study will remain in the laboratory for future research.
|Study Start Date:||September 2009|
|Estimated Primary Completion Date:||January 2019 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT01042548
|Contact: Cathy Van Every, BSN||412-781-3744 ext email@example.com|
|United States, Pennsylvania|
|UPMC St. Margaret||Recruiting|
|Pittsburgh, Pennsylvania, United States, 15215|
|Contact: Cathy Van Every, BSN 412-781-3744 ext 112 firstname.lastname@example.org|
|Principal Investigator: Min Sun, MD, PhD|